Source: good natured Products Inc.
  • good natured Products (TSXV:GDNP) signs two-year contract with Texas-based food producer
  • The company will supply packaging based on its proprietary GoodGuard tamper-evident design
  • It anticipates US$1.2 million in revenue in the first year
  • good natured Products offers a broad assortment of plant-based products made from rapidly renewable resources instead of fossil fuels
  • good natured Products (GDNP) last traded at $0.20 per share

good natured Products (TSXV:GDNP) signs two-year contract with Texas-based food producer.

The client is a regional U.S. snack food producer that distributes across several prominent Texas retailers.

good natured will supply packaging based on its proprietary GoodGuard tamper-evident design. It will produce the packaging at its Houston facility using a customized Bio-PET formulation that is curbside recyclable.

The company anticipates US$1.2 million in revenue in the first year. Initial shipments are slated for Q3 2023.

“This project combines many elements of why we believe good natured is unique in the market,” said Paul Antoniadis, CEO of good natured. “We collaborated closely with this purpose-driven organization in the local community of our Houston facility to build on our Canadian-made GoodGuard tamper-evident innovation and custom-fit a package design uniquely for their business needs.”

“It’s a testament to the robust value proposition we’re taking to market,” he added, “as well as the resilient demand for sustainable packaging despite volatile macroeconomic conditions being faced in more commoditized markets.”

good natured Products offers a broad assortment of plant-based products made from rapidly renewable resources instead of fossil fuels. 

good natured Products (GDNP) last traded at $0.20 per share.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.


More From The Market Online
BriaCell Therapeutics Corp

BriaCell to report positive cancer research at medical convention

BriaCell Therapeutics (TSX:BCT) will present positive clinical data of Bria-IMT at the 2024 American Society of Clinical Oncology in Chicago.

Despite cybersecurity breach, Mainstreet Equity stock is a buy

Mainstreet Equity (TSX:MEQ), a highly profitable property manager with almost 18,000 units, suffered a cybersecurity breach on Tuesday.

@ the Bell: TSX gains on latest economic report

Mining stocks led gainers on the TSX, followed by the financial sector, while the telecom market was the biggest decliner.

BC Transit orders 29 zero-emission buses from NFI subsidiary

NFI Group Inc. (TSX:NFI) subsidiary Alexander Dennis Ltd. receives a firm order for 29 zero-emission Enviro500EV buses from BC Transit.